amrx-20220509

0001723128-22-000019.txt : 20220513 0001723128-22-000019.hdr.sgml : 20220513 20220513163901 ACCESSION NUMBER: 0001723128-22-000019 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 12 CONFORMED PERIOD OF REPORT: 20220509 ITEM INFORMATION: Submission of Matters to a Vote of Security Holders FILED AS OF DATE: 20220513 DATE AS OF CHANGE: 20220513 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Amneal Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001723128 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-38485 FILM NUMBER: 22923433 BUSINESS ADDRESS: BUSINESS PHONE: (908) 947-3120 MAIL ADDRESS: STREET 1: 400 CROSSING BOULEVARD STREET 2: 3RD FLOOR CITY: BRIDGEWATER STATE: NJ ZIP: 08807 FORMER COMPANY: FORMER CONFORMED NAME: Atlas Holdings, Inc. DATE OF NAME CHANGE: 20171117 8-K 1 amrx-20220509.htm 8-K amrx-20220509

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported): May 9, 2022

AMNEAL PHARMACEUTICALS, INC.

(Exact name of registrant as specified in its charter)

Delaware

001-38485

32-0546926

(State or other jurisdiction
of incorporation)

(Commission File Number)

(IRS Employer
Identification No.)

400 Crossing Blvd

Bridgewater, NJ 08807

(Address of principal executive offices) (Zip Code)

Registrant’s telephone number, including area code: (908) 947-3120

N/A

(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:


☐			Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐			Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐			Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐			Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Class A Common Stock, par value $0.01 per share

AMRX

New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐


Item 5.07			Submission of Matters to a Vote of Security Holders.

Amneal Pharmaceuticals, Inc. (the “Company”) held its 2022 Annual Meeting of Stockholders (the “Annual Meeting”) on May 9, 2022. Each of the proposals was approved, and each of the director nominees was elected, by the vote of the stockholders at the Annual Meeting as follows:

Proposal 1: To elect the following director nominees to hold office until the 2023 Annual Meeting of Stockholders and until their respective successors are elected and qualified:




	For		Against		Abstain	Broker Non-Votes
Emily Peterson Alva		233,367,731		4,027,769	270,575		20,029,960
J. Kevin Buchi		200,540,414		36,874,511	251,150		20,029,960
Jeff George		199,259,620		38,156,822	249,633		20,029,960
John Kiely		193,546,651		43,852,884	266,540		20,029,960
Paul Meister		200,167,942		37,242,388	255,745		20,029,960
Ted Nark		207,399,477		30,001,444	265,154		20,029,960
Chintu Patel		236,380,089		1,187,228	98,758		20,029,960
Chirag Patel		236,348,727		1,243,120	74,228		20,029,960
Gautam Patel		233,108,078		4,481,987	76,010		20,029,960
Shlomo Yanai		236,247,636		1,285,233	133,206		20,029,960

Proposal 2: To approve, on a non-binding, advisory basis, the compensation of the Company’s named executive officers:




For	Against	Abstain	Broker Non-Votes
236,202,110	1,193,006	270,959	20,029,960

Proposal 3: To ratify the selection of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2022:




For	Against	Abstain	Broker Non-Votes
256,967,689	253,537	474,809	0

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.


Date: May 13, 2022	AMNEAL PHARMACEUTICALS, INC.

	By:	/s/ Jason B. Daly
	Name:	Jason B. Daly
	Title:	Executive Vice President, Chief Legal Officer and Corporate Secretary

EX-101.SCH 2 amrx-20220509.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 0001001 - Document - Document and Entity Information Document link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 3 amrx-20220509_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Entity Address, Address Line One Entity Address, Address Line One Pre-commencement Issuer Tender Offer Pre-commencement Issuer Tender Offer Entity Address, Postal Zip Code Entity Address, Postal Zip Code Entity Registrant Name Entity Registrant Name Written Communications Written Communications Local Phone Number Local Phone Number Soliciting Material Soliciting Material Entity Address, State or Province Entity Address, State or Province City Area Code City Area Code Document Type Document Type Document Period End Date Document Period End Date Cover [Abstract] Cover [Abstract] Entity Address, City or Town Entity Address, City or Town Pre-commencement Tender Offer Pre-commencement Tender Offer Entity File Number Entity File Number Entity Central Index Key Entity Central Index Key Amendment Flag Amendment Flag Trading Symbol Trading Symbol Entity Tax Identification Number Entity Tax Identification Number Entity Emerging Growth Company Entity Emerging Growth Company Security Exchange Name Security Exchange Name Title of 12(b) Security Title of 12(b) Security Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code EX-101.PRE 4 amrx-20220509_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT XML 5 R1.htm IDEA: XBRL DOCUMENT

Document and Entity Information Document	May 09, 2022
Cover [Abstract]
Document Type	8-K
Amendment Flag	false
Document Period End Date	May 09, 2022
Entity Registrant Name	AMNEAL PHARMACEUTICALS, INC.
Entity Central Index Key	0001723128
Entity Emerging Growth Company	false
Entity File Number	001-38485
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	32-0546926
Entity Address, Address Line One	400 Crossing Blvd
Entity Address, City or Town	Bridgewater
Entity Address, State or Province	NJ
Entity Address, Postal Zip Code	08807
City Area Code	908
Local Phone Number	947-3120
Written Communications	false
Soliciting Material	false
Pre-commencement Tender Offer	false
Pre-commencement Issuer Tender Offer	false
Title of 12(b) Security	Class A Common Stock, par value $0.01 per share
Trading Symbol	AMRX
Security Exchange Name	NYSE

XML 6 amrx-20220509_htm.xml IDEA: XBRL DOCUMENT 0001723128 2022-05-09 2022-05-09 false 0001723128 8-K 2022-05-09 AMNEAL PHARMACEUTICALS, INC. DE 001-38485 32-0546926 400 Crossing Blvd Bridgewater NJ 08807 908 947-3120 false false false false Class A Common Stock, par value $0.01 per share AMRX NYSE false EXCEL 7 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 8 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 9 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 10 FilingSummary.xml IDEA: XBRL DOCUMENT 3.22.1 html 1 22 1 false 0 0 false 0 false false R1.htm 0001001 - Document - Document and Entity Information Document Sheet http://www.amneal.com/role/DocumentandEntityInformationDocument Document and Entity Information Document Cover 1 false false All Reports Book All Reports amrx-20220509.htm amrx-20220509.xsd amrx-20220509_lab.xml amrx-20220509_pre.xml http://xbrl.sec.gov/dei/2021q4 true false JSON 12 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "amrx-20220509.htm": { "axisCustom": 0, "axisStandard": 0, "contextCount": 1, "dts": { "inline": { "local": [ "amrx-20220509.htm" ] }, "labelLink": { "local": [ "amrx-20220509_lab.xml" ] }, "presentationLink": { "local": [ "amrx-20220509_pre.xml" ] }, "schema": { "local": [ "amrx-20220509.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd" ] } }, "elementCount": 23, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2021q4": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 22, "memberCustom": 0, "memberStandard": 0, "nsprefix": "amrx", "nsuri": "http://www.amneal.com/20220509", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "amrx-20220509.htm", "contextRef": "i2847c600fdd2497b9c0fa8555fa08502_D20220509-20220509", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "0001001 - Document - Document and Entity Information Document", "role": "http://www.amneal.com/role/DocumentandEntityInformationDocument", "shortName": "Document and Entity Information Document", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "amrx-20220509.htm", "contextRef": "i2847c600fdd2497b9c0fa8555fa08502_D20220509-20220509", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.amneal.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.amneal.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]", "terseLabel": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.amneal.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "dateItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.amneal.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.amneal.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.amneal.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.amneal.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province", "terseLabel": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.amneal.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.amneal.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.amneal.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.amneal.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "fileNumberItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code", "terseLabel": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.amneal.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.amneal.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.amneal.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.amneal.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "normalizedStringItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer", "terseLabel": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.amneal.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer", "terseLabel": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.amneal.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security", "terseLabel": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.amneal.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.amneal.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material", "terseLabel": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.amneal.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.amneal.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications", "terseLabel": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.amneal.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "booleanItemType" } }, "unitCount": 0 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r5": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r6": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" } }, "version": "2.1" } ZIP 13 0001723128-22-000019-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001723128-22-000019-xbrl.zip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